[A study on tolerance to denopamine, oral beta 1-agonist]

Area of Science:

• Cardiology
• Pharmacology

Context:

• Heart failure (HF) is a complex syndrome characterized by impaired cardiac function.
• Denopamine is an inotropic agent investigated for its effects on cardiovascular parameters.

Purpose:

• To evaluate the sustained efficacy and potential diminishing effects of denopamine in patients with heart failure.
• To compare the acute and chronic effects of denopamine on cardiac function and hemodynamics.

Summary:

• Chronic denopamine treatment (30 mg/day for ~40 days) in 23 NYHA II-III heart failure patients led to a significant decrease in left ventricular end-diastolic dimension (p<0.01) and increased percent fractional shortening (%FS) (p<0.05) and cardiac index (CI) (p<0.01).
• Acute single-dose administration of denopamine (10 mg) also significantly increased %FS, mean velocity of circumferential fiber shortening (mVCF), and CI.
• Following long-term treatment, single-dose denopamine continued to show significant increases in mVCF (p<0.05) and CI (p<0.01), indicating sustained positive inotropic effects.

Impact:

• Denopamine demonstrates sustained therapeutic benefits in improving cardiac contractility and output in heart failure patients.
• The study suggests that denopamine's positive effects on cardiac function are maintained with chronic administration, without significant adverse hemodynamic changes.
• Findings support the potential role of denopamine as a long-term treatment option for heart failure.